# Assessment of Early-detection Based on Liquid Biopsy in Lung Cancer (ASCEND-LUNG)

> **NCT04817046** · — · UNKNOWN · sponsor: **Peking University People's Hospital** · enrollment: 467 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04817046
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-19
- **Primary completion:** 2022-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 467 (ESTIMATED)
- **Last updated:** 2021-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04817046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04817046, "Assessment of Early-detection Based on Liquid Biopsy in Lung Cancer (ASCEND-LUNG)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04817046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*